Atlas Trials

Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT03760523 · TERMINATED

Trial details

NCT number
NCT03760523
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2019-04-18
Primary completion
2023-10-09
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.